Complete closure after colorectal endoscopic submucosal dissection with a re-openable clip with a sharp claw.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
25 Sep 2024
Historique:
medline: 26 9 2024
pubmed: 26 9 2024
entrez: 25 9 2024
Statut: aheadofprint

Résumé

The MANTIS Closure Device (MCD: Boston Scientific, USA), a reopenable clip with a sharp claw, is a closure device used after endoscopic submucosal dissection (ESD). We aimed to evaluate the effectiveness of MCD for fast and complete closure after colorectal ESD. Cases that underwent closure with MCD after ESD of colorectal lesions 20-60 mm between April 2023 and January 2024 were reviewed. The primary endpoint was the complete closure of the ESD defect with MCD. Secondary endpoints included closure time, delayed bleeding (DB), perforation (DP), and post-ESD coagulation syndrome (PECS). The usage of MCD involved 1. grasping the anal-side mucosa around the defect, 2. pushing it toward the oral-side mucosa around the defect and deploying it, 3. adding several re-openable clips (Sure clip, Micro-Tech, China) for complete closure. Sixty-one cases with MCD were analyzed. The mean tumor size was 32.3±9.2 mm. The complete closure rate was 98.4% and closure time (mean±standard deviation: SD) was 6.9±2.6 mins. The number of MCD and Sure clip (mean±SD) were 1.0±0.1 and 4.7±1.4. The rates of DP/DB/PECS were 0%, 0%, and 9.8%, respectively. Fast and complete closure after colorectal ESD was successfully achieved using MCD.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
The MANTIS Closure Device (MCD: Boston Scientific, USA), a reopenable clip with a sharp claw, is a closure device used after endoscopic submucosal dissection (ESD). We aimed to evaluate the effectiveness of MCD for fast and complete closure after colorectal ESD.
METHODS METHODS
Cases that underwent closure with MCD after ESD of colorectal lesions 20-60 mm between April 2023 and January 2024 were reviewed. The primary endpoint was the complete closure of the ESD defect with MCD. Secondary endpoints included closure time, delayed bleeding (DB), perforation (DP), and post-ESD coagulation syndrome (PECS). The usage of MCD involved 1. grasping the anal-side mucosa around the defect, 2. pushing it toward the oral-side mucosa around the defect and deploying it, 3. adding several re-openable clips (Sure clip, Micro-Tech, China) for complete closure.
RESULTS RESULTS
Sixty-one cases with MCD were analyzed. The mean tumor size was 32.3±9.2 mm. The complete closure rate was 98.4% and closure time (mean±standard deviation: SD) was 6.9±2.6 mins. The number of MCD and Sure clip (mean±SD) were 1.0±0.1 and 4.7±1.4. The rates of DP/DB/PECS were 0%, 0%, and 9.8%, respectively.
CONCLUSION CONCLUSIONS
Fast and complete closure after colorectal ESD was successfully achieved using MCD.

Identifiants

pubmed: 39321960
doi: 10.1055/a-2421-9767
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

Naohisa Yoshida and Osamu Dohi received research grants from Fujifilm. Other authors did not have any conflict of interests.

Auteurs

Naohisa Yoshida (N)

Molecular gastroenterology and hepatology, Kyoto prefectural university of medicine, Kyoto, Japan, Kyoto, Japan.

Ryohei Hirose (R)

Molecular Gastroenterology, Kyoto Perfectural University of Medicine, Kyoto, Japan.

Osamu Dohi (O)

Department of Gastroenterology and Hepatology, Kyoto Furitsu Ika Daigaku, Kyoto, Japan.

Yoshikazu Inagaki (Y)

Gastroenterology, Nishijin Hospital, Kyoto, Japan.

Takaaki Murakami (T)

Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.

Yutaka Inada (Y)

Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Yasutaka Morimoto (Y)

Department of Gastroenterology, Matsushita Memorial Hospital, Kyoto, Japan.

Reo Kobayashi (R)

Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Ken Inoue (K)

Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Elsayed Ghoneem (E)

Hepatology and Gastroenterology Unit, Internal Medicine Department, Mansoura University, Mansoura, Egypt.
Department of Molecular gastroenterology and hepatology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Yoshito Itoh (Y)

Molecular of Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.

Classifications MeSH